Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate Tablet
Product Images NDC 72516-014

6 FDA label images from Oryza Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 72516-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oryza Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container Label 5 mg (Final Labeling)

Container Label 5 mg (Final Labeling)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 5 mg strength, in a package of 100 tablets. The product is manufactured by Oryza Pharmaceuticals Inc. The label includes dosage information, storage instructions, and a barcode.*
FDA Label Image

Container Label 7.5 mg (Final Labeling 1)

Container Label 7.5 mg (Final Labeling 1)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate tablets, 7.5 mg strength, oral dosage form. The label shows the product name, strength, dosage form as tablets, quantity of 100 tablets, and manufacturer Oryza Pharmaceuticals Inc. It includes a note to dispense the accompanying medication guide and storage instructions.*
FDA Label Image

Container Label 10 mg (Final Labeling 2)

Container Label 10 mg (Final Labeling 2)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate tablets, 10 mg strength, oral dosage form. The label indicates it contains 100 tablets, Rx only, manufactured by Oryza Pharmaceuticals Inc. It includes dosage content per tablet and storage instructions, along with the NDC number 72516-014-01.*
FDA Label Image

Container Label 15 mg (Final Labeling 3)

Container Label 15 mg (Final Labeling 3)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets by Oryza Pharmaceuticals Inc. The label shows a strength of 15 mg, with 100 tablets in the package. It includes usage, storage, and dispensing instructions, as well as a barcode.*
FDA Label Image

Container Label 20 mg (Final Labeling 4)

Container Label 20 mg (Final Labeling 4)
Packaging label for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets by Oryza Pharmaceuticals Inc. It states the combined active ingredient strength as 20 mg, with 100 tablets in the container. The label includes dosage information, storage instructions, and a barcode.*
FDA Label Image

Container Label 30 mg (Final Labeling 5)

Container Label 30 mg (Final Labeling 5)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate tablets, 30 mg strength, oral dosage form. The label indicates 100 tablets packaged by Oryza Pharmaceuticals Inc. It includes prescription and storage instructions, dosage caution, and a barcode with labeler information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.